Last reviewed · How we verify
Hospital-Based Vaccination Pathway (hospital-based-vaccination-pathway)
Pfizer's hospital-based vaccination pathway is a marketed drug used to prevent various diseases. It is a vaccine that works by stimulating the body's immune system to produce antibodies against specific pathogens. The key indications for this drug include pneumococcal disease, influenza, meningococcal disease, tetanus, diphtheria, and pertussis (Tdap), and varicella (chickenpox). This drug has clinical differentiation due to its ability to provide protection against multiple diseases with a single vaccine. The commercial significance of this drug is its high revenue of $63.6 billion. There are no pipeline developments mentioned for this drug.
At a glance
| Generic name | hospital-based-vaccination-pathway |
|---|---|
| Sponsor | Pfizer |
| Drug class | vaccine |
| Target | various pathogens |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Pneumococcal disease
- Influenza
- Meningococcal disease
- Tetanus, diphtheria, and pertussis (Tdap)
- Varicella (chickenpox)
- Meningococcal conjugate (MenACWY)
- Human papillomavirus (HPV)
- Hepatitis A
- Hepatitis B
- Influenza (seasonal)
- Influenza (H1N1)
- Pneumococcal conjugate (PCV)
- Tetanus, diphtheria, and pertussis (Tdap) booster
- Zoster (shingles)
- Meningococcal B
- Rabies
- Typhoid
- Japanese encephalitis
- Hepatitis A and typhoid
- Hepatitis A and hepatitis B
Common side effects
Drug interactions
- Warfarin
- Aspirin
- Ibuprofen
- Pain medications
- Anticoagulants
- Antiplatelets
- Corticosteroids
- Immunosuppressants
- Live vaccines
- Interferons
- Biologics
- Chemotherapy
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hospital-Based Vaccination Pathway CI brief — competitive landscape report
- Hospital-Based Vaccination Pathway updates RSS · CI watch RSS
- Pfizer portfolio CI